Patents Represented by Attorney, Agent or Law Firm Francis O. Ginah
  • Substituted tricyclics
    Patent number: 6448284
    Abstract: A class of tricycles is disclosed together with the use of such for inhibiting Spla2 mediated release of fatty acids for the treatment of conditions such as septic shock.
    Type: Grant
    Filed: June 20, 2001
    Date of Patent: September 10, 2002
    Assignee: Eli Lilly and Company
    Inventors: Nicholas James Bach, Daniel Jon Sall
  • Process for preparing 4-hdyroxy indole, indazole and carbazole compounds
    Patent number: 6407261
    Abstract: A process for preparing 4-hydroxy carbazoles useful as intermediates for preparing compounds that are useful for inhibiting sPLA2 and novel intermediates.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: June 18, 2002
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Alan Anderson, Nancy Kay Harn
  • Process for preparing 4-substituted-1H-indole-3-glyoxamides
    Patent number: 6380397
    Abstract: A process for preparing 1H-indole-3-glyoxamides useful for inhibiting SPLA2 and novel intermediates useful in the preparation of such compounds.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: April 30, 2002
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Alan Anderson, Nancy Kay Harn, Richard Duane Miller, Edward Francis Plocharczyk
  • Hypoglycemic and hypolipidemic compounds
    Patent number: 6353027
    Abstract: This invention provides compounds and their pharmaceutically-acceptable salts, pharmaceutical formulations of said compounds, and methods for treating hyperglycemia associated with non-insulin dependent diabetes and for treating hyperlipidemia.
    Type: Grant
    Filed: March 3, 2000
    Date of Patent: March 5, 2002
    Assignee: Eli Lilly and Company
    Inventors: Samuel James Dominianni, Margaret Mary Faul, Russell Dean Stucky, Leonard Larry Winneroski, Jr.
  • Phenyl acetamides as sPLA2 inhibitors
    Patent number: 6353128
    Abstract: A class of novel phenyl acetamides is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
    Type: Grant
    Filed: November 24, 1997
    Date of Patent: March 5, 2002
    Assignee: Eli Lilly and Company
    Inventors: Theodore Goodson, Jr., Richard Waltz Harper, David Kent Herron
  • Process for preparing 4-substituted-1h-indole-3-glyoxamides
    Patent number: 6265591
    Abstract: A process for preparing 1H-indole-3-glyoxamides useful for inhibiting SPLA2 and novel intermediates useful in the preparation of such compounds.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: July 24, 2001
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Alan Anderson, Nancy Kay Harn
  • Hypoglycemic and hypolipidemic compounds
    Patent number: 6194446
    Abstract: This invention provides compounds and their pharmaceutically-acceptable salts, pharmaceutical formulations of said compounds, and methods for treating hyperglycemia associated with non-insulin dependent diabetes and for treating hyperlipidemia.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: February 27, 2001
    Assignee: Eli Lilly and Company
    Inventors: Samuel James Dominianni, Margaret Mary Faul, Russell Dean Stucky, Leonard Larry Winneroski, Jr.
  • Hypoglycemic and hypolipidemic compounds
    Patent number: 6121282
    Abstract: This invention provides 1,2,3,4-tetrahydroisoquinoline compounds and their pharmaceuticallyacceptable salts, pharmaceutical formulations of said compounds, and methods for treating hyperglycemia associated with non-insulin dependent diabetes and for treating hyperlipidemia.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: September 19, 2000
    Assignee: Eli Lilly and Company
    Inventors: Samuel James Dominianni, William Harlan Gritton